Dermatology Times

MARCH 14, 2024

A panel of experts discusses unique needs of patients with skin of color, look at long-term safety and efficacy of emerging oral treatments, and delve into combining topicals with systemic therapies.

Management 74

Management Safety Therapy Treatments 74

Spa Industry Association

APRIL 4, 2024

Spa owners and managers must keep their customers and employees safe. Ignoring safety regulations and requirements can lead to severe health issues that can cause them to be held liable for any damages that occur. Continue reading 4 Tips for Ensuring Spa Safety at Spa Industry Association.

Safety 40

Safety Management 40

Dermatology Times

APRIL 12, 2024

Dr Alexandra Golant discusses managing multiple conditions in a 17-year-old African American waitress, highlighting the complexities of treating moderate-to-severe atopic dermatitis alongside severe acne and oral contraceptives. She also addresses potential drug interactions, focusing on the safety of dupilumab in systemic treatment.

Dermatitis 85

Dermatitis Treatments Safety Management 85

Spa Executive

MARCH 14, 2025

Booking and operations without friction The ability to smoothly book an exclusive, tech-free wellness experience still depends on cloud-based reservation systems that optimize scheduling, guest preferences, and inventory management. Tech-free, but not inconvenient Guests may want to disconnect, but they dont want inconvenience.

Social Media 52

Social Media Hospital Technology Branding 52

AAAMS

JANUARY 21, 2025

Safe and Effective Procedures: Training ensures that your practitioners understand the proper techniques and safety protocols, minimizing risks and enhancing the quality of results. Enhanced Client Trust : Clients are more likely to choose a med spa where practitioners are certified, knowing their safety and satisfaction are prioritized.

Med Spa 52

Med Spa Chemical Peels Training Legal 52

Dermatology Times

OCTOBER 29, 2024

Explore the groundbreaking findings from the Effisayil 2 trial on the efficacy and safety of subcutaneous spesolimab in preventing flares of generalized pustular psoriasis.

Safety 36

Safety Management 36

Dermatology Times

MARCH 9, 2025

Gold emphasized the necessity of recognizing and managing complications in aesthetic dermatology to ensure patient safety and optimal outcomes.

Dermatology 67

Dermatology Safety Management 67

Dermatology Times

JANUARY 2, 2025

The panelist discusses how safety data from clinical trials and real-world evidence should guide physicians in prescribing ruxolitinib cream, including patient monitoring protocols and managing potential adverse effects in atopic dermatitis treatment.

Safety 36

Safety Dermatitis Management Clinic 36

The Dermatology Digest

DECEMBER 9, 2024

This FDA clearance was supported by AiVivas submission of safety data on non-facial skin tolerability and efficacy, and systemic exposure from 67 subjects treated with AIV001 in basal cell carcinoma and in scar management. AIV001 is a pan-tyrosine kinase inhibitor in a proprietary formulation designed for prolonged drug release.

Injections 36

Injections Facials Scarring Sensitive Skin 36

The Dermatology Digest

DECEMBER 3, 2024

“Today’s MHRA approval of delgocitinib cream marks a significant milestone for adults in Great Britain living with moderate to severe Chronic Hand Eczema,” says Leanne Walsh, Vice President and General Manager, LEO Pharma UK and Ireland, in a news release. Both trials met their primary and all secondary endpoints.

Marketing 36

Marketing Eczema Safety Management 36

The Dermatology Digest

NOVEMBER 6, 2024

Five researchers have been awarded the 2024 Translational Bridge Award to tackle pressing issues, from managing pain and fatigue to developing an alternative to the widely used glucocorticoids. ” The TBA recipients include: Innovating Pain and Fatigue Management Cynthia Aranow, MD, The Feinstein Institutes for Medical Research Dr. .

Hospital 36

Hospital Therapy Networking Management 36

AAAMS

DECEMBER 19, 2024

Understanding patient safety protocols and treatment planning. Understand how to manage challenging cases effectively. Enrolling in programs like those offered by AAAMS ensures you receive hands-on training, practical experience, and industry-recognized credentials. Learn patient communication and consultation strategies.

Social Media 52

Social Media Work-Life Balance Training Microneedling 52

Southeastern Esthetics Institute

AUGUST 23, 2016

Thorough organization of charting systems, patient and employee safety and sanitation practices, and consistent monitoring by supervisory staff is the key to medical spa success. Proper communication is exceptionally important between the physician and support staff when treating patients in a medical setting.

Esthetician 195

Esthetician Esthetics Document Office 195

The Dermatology Digest

APRIL 12, 2024

Recent cases where possibly counterfeit neurotoxins in Illinois and Tennessee led to a cluster of illnesses resembling Botulism highlight the need to strengthen patient safety through increased oversight of medical care in all settings, according to the American Society for Dermatologic Surgery Association (ASDSA).

Safety 69

Safety Surgery Medical Training 69

The Dermatology Digest

NOVEMBER 21, 2023

In Part 3 of this educational video series, Dr. Christopher Belcher discusses the safety and efficacy of Natroba (Spinosad) 0.9% The series reviews the treatment landscape for scabies, with an examination of current treatment paradigms and case-based disease management. topical FDA-approved for the treatment of head lice and scabies.

Management 36

Management Education Safety Treatments 36

The Dermatology Digest

NOVEMBER 21, 2023

In Part 3 of this educational video series, Dr. Christopher Belcher discusses the safety and efficacy of Natroba (Spinosad) 0.9% The series reviews the treatment landscape for scabies, with an examination of current treatment paradigms and case-based disease management. topical FDA-approved for the treatment of head lice and scabies.

Management 36

Management Education Safety Treatments 36

The Dermatology Digest

APRIL 2, 2024

The series reviews the treatment landscape for scabies, with an examination of current treatment paradigms and case-based disease management. In Part 3 of this educational video series, Dr. Christopher Belcher discusses the safety and efficacy of Natroba (Spinosad) 0.9% topical FDA-approved for the treatment of head lice and scabies.

Management 36

Management Education Safety Treatments 36

The Dermatology Digest

DECEMBER 15, 2023

The comprehensive safety analysis establishes evidence regarding the safety of systematic Janus kinase inhibitors in patients with atopic dermatitis. They reviewed the available safety data and analyzed the risk of 11 adverse events from 14 RCTs published between 2019 and 2022.

Safety 36

Safety Dermatitis Dermatology Management 36

The Dermatology Digest

SEPTEMBER 26, 2024

The safety profile was consistent with that previously reported, the study showed. Safety is not an issue. So, with the right selection of the right patient, there’s a benefit in long-term management. Improvements in itch, sleep, and QoL were also observed over time. We don’t see any conjunctivitis.

Dermatitis 74

Dermatitis Safety Management Eczema 74

The Dermatology Digest

DECEMBER 15, 2023

They reviewed the available safety data and analyzed the risk of 11 adverse events from 14 RCTs published between 2019 and 2022. The post Review Study Aims to Refine Safety Profile of JAK Inhibitors in AD appeared first on The Dermatology Digest.

Safety 36

Safety Dermatitis Dermatology Management 36

Dermatology Times

DECEMBER 5, 2024

Panelists discuss how current HS treatments, ranging from topical antibiotics to biologics, show varying degrees of efficacy in managing symptoms, while highlighting the need for individualized treatment approaches based on disease severity and patient factors.

Safety 36

Safety Treatments Management 36

Dermatology Times

NOVEMBER 15, 2024

Panelists discuss common misconceptions about the mechanism of action of PDE4 inhibitors in clinical practice, emphasizing that not all PDE4 inhibitors are created equal and how these differences can significantly impact their efficacy and safety profiles.

Management 36

Management Safety Clinic 36

US Dermatologt Partners

JANUARY 13, 2025

Acne is one of the most frustrating skin conditions, and breakouts can be very difficult to manage. While many people consider dermatologic acne extractions as a cosmetic solution to clear breakouts up more quickly, acne extractions play a pivotal role in managing acne breakouts. According to Dr. Kavya Desai of U.S.

Extractions 41

Extractions Scarring Pores Chemical Peels 41

Dermatology Times

JANUARY 17, 2025

A panelist discusses how the advent of targeted systemic therapies such as dupilumab and nemolizumab has transformed the treatment landscape for prurigo nodularis, offering more effective options for breaking the itch-scratch cycle while maintaining favorable safety profiles compared with traditional systemic treatments.

Management 36

Management Safety Therapy Treatments 36

Lipgloss and Aftershave

OCTOBER 30, 2024

This versatility makes our devices suitable for a wide range of skin tones, from lighter to darker Fitzpatrick types, while maintaining comfort and safety. IPL allows for various skin treatments, including pigmentation correction, vascular lesion treatment, acne management, and skin rejuvenation.

Hair Removal 52

Hair Removal Skin Types Technology Safety 52

The Dermatology Digest

JULY 16, 2024

Visitors will receive samples of La Roche-Posay’s Anthelios sun care products along with sun safety information. As the industry leader in sun protection, we are proud to partner with Edge on this exciting experience during peak summer season,” says Rachelle Mladjenovic, General Manager at La Roche-Posay USA.

Sun Protection 74

Sun Protection Partnerships Office Safety 74

The Dermatology Digest

MARCH 3, 2025

The long-term safety and efficacy of B-VEC is further supported by results from the Companys open label extension study completed in the United States as well as real-world experience with B-VEC since launching the United States in 2023.

Therapy 36

Therapy Clinic Hospital Dermatology 36

West Lake Dermatology

JANUARY 6, 2025

GLP-1 medications, such as semaglutide and tirzepatide , are groundbreaking treatments for weight loss and diabetes management. Missing doses or injecting too frequently can affect the medication’s efficacy and safety. However, many new patients express reservations about one specific aspect: self-injections.

Injections 36

Injections Medical Irritation Scarring 36

Dermatology Times

MARCH 28, 2024

Drs Mark Lebwohl and Saakshi Khattri review the significance of long-term data of bimekizumab for plaque psoriasis management.

Safety 36

Safety Management 36

The Dermatology Digest

FEBRUARY 14, 2024

The regulatory submissions of nemolizumab in prurigo nodularis are based on data from the phase III OLYMPIA clinical trial program, which evaluated the efficacy and safety of nemolizumab administered subcutaneously every four weeks in patients with prurigo nodularis.

Dermatitis 78

Dermatitis Clinic Safety Dermatology 78

The Dermatology Digest

MARCH 5, 2024

.” Coral Gables, FL-based dermatologist Joely Kaufman, MD, adds, “The results from the clinical trials for letibotulinumtoxinA demonstrate efficacy, and a convincing safety profile in the treatment of glabellar lines. and Europe. Hugel resubmitted its application in October 2022 and was denied approval again in 2023.

Branding 74

Branding Injections Safety Facials 74

The Dermatology Digest

FEBRUARY 14, 2024

We are confident, that VTAMA cream, if approved by the FDA, will be well positioned as a safe, well-tolerated, steroid-free topical treatment option for patients 2 years of age and older with AD and could provide for long-term disease management, representing meaningful advancement for patients, caregivers, and healthcare providers.”

Dermatitis 74

Dermatitis Office Management Eczema 74

Dermatology Times

JULY 8, 2024

Robert Bruce Posnick, MD, examines a case of a 55-year-old female patient with a 50-year history of atopic dermatitis, comorbid asthma, and severe alopecia areata, presenting with recurrent patches throughout her body, predominantly affecting her face, hands, trunk, arms, legs, and eyelids.

Dermatitis 36

Dermatitis Safety Management Treatments 36

The Dermatology Digest

JANUARY 29, 2024

The STudy of Roflumilast foam Applied Topically for the redUction of seborrheic derMatitis (STRATUM) was a parallel group, double-blind, vehicle-controlled study evaluating the safety and efficacy of Zoryve (roflumilast) foam, 0.3% Zoryve foam was well-tolerated with a favorable safety and tolerability profile.

Dermatitis 74

Dermatitis Safety Dermatology Treatments 74

The Dermatology Digest

MARCH 14, 2025

Together, Novartis and the NFL are working toward leveling the playing field against serious health conditions, empowering every fan to proactively manage their health.”

Pharmaceutical 36

Pharmaceutical Partnerships Medical Office 36

The Dermatology Digest

MARCH 3, 2025

REMIX-1/-2 are identical, multicenter, randomized, double-blind, placebo-controlled Phase 3 trials assessing the efficacy and safety of remibrutinib in patients with CSU remaining symptomatic despite second-generation H 1 -antihistamines. CSU is not a difficult disease to diagnose and manage. Dr. Metz: My recommendation is very simple.

Sustainability 36

Sustainability Dermatology Safety Management 36

Spa Industry Association

SEPTEMBER 19, 2023

Embarking on a journey of managing back pain through massage therapy is often an exciting prospect. However, it’s also essential to navigate this path with safety in mind. When suffering from back pain, you must understand when it’s safe and beneficial to get a massage and when it might not be the best idea.

Safety 52

Safety Therapy Management 52